# Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)

> **NCT07059936** · — · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 350 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07059936
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07059936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07059936, "Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07059936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*